Literature DB >> 22295904

Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.

Seema Mittal1, Yufeng Cai, Madhavi N L Nalam, Daniel N A Bolon, Celia A Schiffer.   

Abstract

Human immunodeficiency virus Type-1 (HIV-1) protease is crucial for viral maturation and infectivity. Studies of protease dynamics suggest that the rearrangement of the hydrophobic core is essential for enzyme activity. Many mutations in the hydrophobic core are also associated with drug resistance and may modulate the core flexibility. To test the role of flexibility in protease activity, pairs of cysteines were introduced at the interfaces of flexible regions remote from the active site. Disulfide bond formation was confirmed by crystal structures and by alkylation of free cysteines and mass spectrometry. Oxidized and reduced crystal structures of these variants show the overall structure of the protease is retained. However, cross-linking the cysteines led to drastic loss in enzyme activity, which was regained upon reducing the disulfide cross-links. Molecular dynamics simulations showed that altered dynamics propagated throughout the enzyme from the engineered disulfide. Thus, altered flexibility within the hydrophobic core can modulate HIV-1 protease activity, supporting the hypothesis that drug resistant mutations distal from the active site can alter the balance between substrate turnover and inhibitor binding by modulating enzyme activity.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22295904      PMCID: PMC3391577          DOI: 10.1021/ja2095766

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  30 in total

Review 1.  Proteins in action: the physics of structural fluctuations and conformational changes.

Authors:  Fritz G Parak
Journal:  Curr Opin Struct Biol       Date:  2003-10       Impact factor: 6.809

2.  Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease.

Authors:  José C Clemente; Rebecca E Moose; Reena Hemrajani; Lisa R S Whitford; Lakshmanan Govindasamy; Robbie Reutzel; Robert McKenna; Mavis Agbandje-McKenna; Maureen M Goodenow; Ben M Dunn
Journal:  Biochemistry       Date:  2004-09-28       Impact factor: 3.162

3.  Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.

Authors:  R B Rose; C S Craik; R M Stroud
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

4.  HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

Authors:  R A Kramer; M D Schaber; A M Skalka; K Ganguly; F Wong-Staal; E P Reddy
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

5.  Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function.

Authors:  R Ishima; D I Freedberg; Y X Wang; J M Louis; D A Torchia
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

6.  Model building of disulfide bonds in proteins with known three-dimensional structure.

Authors:  B Hazes; B W Dijkstra
Journal:  Protein Eng       Date:  1988-07

7.  Disulphide bridges in globular proteins.

Authors:  J M Thornton
Journal:  J Mol Biol       Date:  1981-09-15       Impact factor: 5.469

8.  A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.

Authors:  Salman Muzammil; Patrick Ross; Ernesto Freire
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

9.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.

Authors:  Alexander L Perryman; Jung-Hsin Lin; J Andrew McCammon
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

View more
  28 in total

1.  Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.

Authors:  Ayşegül Özen; Kuan-Hung Lin; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-29       Impact factor: 11.205

2.  Predicting X-ray solution scattering from flexible macromolecules.

Authors:  Hao Zhou; Hugo Guterres; Carla Mattos; Lee Makowski
Journal:  Protein Sci       Date:  2018-10-16       Impact factor: 6.725

3.  Small molecule regulation of protein conformation by binding in the Flap of HIV protease.

Authors:  Theresa Tiefenbrunn; Stefano Forli; Michael M Baksh; Max W Chang; Meaghan Happer; Ying-Chuan Lin; Alexander L Perryman; Jin-Kyu Rhee; Bruce E Torbett; Arthur J Olson; John H Elder; M G Finn; C David Stout
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

4.  Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation.

Authors:  Yufeng Cai; Nese Kurt Yilmaz; Wazo Myint; Rieko Ishima; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2012-04-17       Impact factor: 6.006

5.  Identifying binding hot spots on protein surfaces by mixed-solvent molecular dynamics: HIV-1 protease as a test case.

Authors:  Peter M U Ung; Phani Ghanakota; Sarah E Graham; Katrina W Lexa; Heather A Carlson
Journal:  Biopolymers       Date:  2016-01       Impact factor: 2.505

6.  Modulation of HIV protease flexibility by the T80N mutation.

Authors:  Hao Zhou; Shangyang Li; John Badger; Ellen Nalivaika; Yufeng Cai; Jennifer Foulkes-Murzycki; Celia Schiffer; Lee Makowski
Journal:  Proteins       Date:  2015-09-29

7.  Uniquely localized intra-molecular amino acid concentrations at the glycolytic enzyme catalytic/active centers of Archaea, Bacteria and Eukaryota are associated with their proposed temporal appearances on earth.

Authors:  J Dennis Pollack; David Gerard; Dennis K Pearl
Journal:  Orig Life Evol Biosph       Date:  2013-05-29       Impact factor: 1.950

8.  Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase.

Authors:  Paul L Boyer; Kalyan Das; Eddy Arnold; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

Review 9.  Improving Viral Protease Inhibitors to Counter Drug Resistance.

Authors:  Nese Kurt Yilmaz; Ronald Swanstrom; Celia A Schiffer
Journal:  Trends Microbiol       Date:  2016-04-15       Impact factor: 17.079

10.  Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease.

Authors:  Ian Mitchelle S de Vera; Adam N Smith; Maria Cristina A Dancel; Xi Huang; Ben M Dunn; Gail E Fanucci
Journal:  Biochemistry       Date:  2013-05-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.